Diagnostic and differential diagnosis of benign prostate syndrome (BPS)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aarnink RG, De la Rosette JJ, Debruyne FMJ et al (1996) Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. Br J Urol 78:219–223
Aarnink RG, De la Rosette JJ, Debruyne FMJ et al (1996) Formula-derived prostate volume determination. Eur Urol 29:399–402
Abrams P, Blaivas JG, Stanton SL et al (1988) The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol 5–19
Abrams P (1994) New words for old: lower urinary tract symptoms for „prostatism“. Br Med J 308:929–930
Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178
Abrams P, D’Ancona LC, Griffith D et al (2006) Lower urinary tract symptom: etiology, patient assessment and predicting outcome from therapy. In: McConnell J, Abrams P, Denis L et al (eds) Male lower urinary tract dysfunction evaluation and management. 6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases, Paris, pp 69–142
Ahyai SA, Lehrich K, Kuntz RM (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 52:1456–1463
Ameda K, Koyanagi T, Nantani M et al (1994) The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy. J Urol 152:443–447
Andersen JT, Wolf H, Ekman P et al (1996) Finasteride in symtomatic benign prostatic hypertrophy. A 2-year placebo-controlled study. Ugeskr Laeger 158:5030–5035
Anderson JB, Roehborn CG, Schalken JA et al (2001) The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur Urol 39:390–399
Anderson JR, Strickland D, Corbin D et al (1995) Age-specific reference ranges for serum prostate-specific antigen. Urology 46:54–57
Anyanwu SN (1995) Is routine urography necessary in all patients undergoing suprapubic transvesical prostatectomy? East Afr Med J 72:78–80
AUA Practice Guidelines Committee (2003) AUA guideline on management of benign prostatic hyperplasia. Chapter 1: diagnosis and treatment recommendations. J Urol 170:530–547
Bachmann A, Schurch L, Ruszat R et al (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48:965–972
Barry MJ, Cockett AT, Holtgrewe HL et al (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150:351–358
Belal M, Abrams P (2006) Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach. J Urol 176:22–28
Bergdahl S, Aus G, Lodding P et al (1999) Transrectal ultrasound with separate measurement of the transition zone predicts the short-term outcome after transurethral resection of the prostate. Urology 53:926–930
Berges R, Pientka L (1999) Management of the BPH syndrome in Germany: who is treated how? Eur Urol 36(Suppl 3): 21–27
Berges R, Pientka L, Hoefner K et al (2001) Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol 39:682–687
Bosch JLHR (1995) Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World J Urol 13:17–20
Bosch JLHR, Hop WCJ, Kirkels WJ et al (1995) The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75:622–630
Bruskewitz RC, Iversen P, Madsen PO (1982) Value of postvoided residual urine determination in evaluation of prostatism. Urology 20:602–604
Chancellor MB, Blaivas JG, Kaplan SA et al (1991) Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow. J Urol 145:810–812
Chandiramani VA, Palace J, Fowler CJ (1997) How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol 80:100–104
Cimentepe E, Unsal A, Saglam R (2003) Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 17:103–107
De la Rosette JJ, de Wildt MJ, Höfner K et al (1996) Pressure-flow-study analysis in patients treated with high energy thermotherapy. J Urol 156:1428–1433
Djavan B, Roehrborn CG, Shariat S et al (1999) Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. J Urol 161:139–143
Djavan B, Seitz C, Roehrborn CG et al (2001) Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 57:66–70
Dörsam J, Kälble T, Riedasch G et al (1994) Wertigkeit der bildgebenden Diagnostik bei benigner Prostatahyperplasie und beim Prostatakarzinom. Radiologe 34:101–108
Drach GW, Layton TN, Binard W (1979) Male peak flow rate: Relationship to volume voided and age. J Urol 122:210–214
El Din KE, Kiemeney LA, de Wildt MJ et al (1996) Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score. Urology 48:393–397
El Din KE, Koch WF, de Wildt MJ et al (1996) The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur Urol 30:409–413
Emberton M, Andriole GL, de La Rosette JJ et al (2003) Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61:267–273
Eri LM, Wessel N, Tysland O et al (2002) Comparative study of pressure-flow parameters. Neurourol Urodyn 21:186–193
Frimodt MP, Jensen KM, Iversen P et al (1984) Analysis of presenting symptoms in prostatism. J Urol 132:272–276
Gerber GS (1996) The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 48:668–675
Gilpin SA, Gosling JA, Barnard RJ (1985) Morphological and morphometric studies of the human obstructed, trabeculated urinary bladder. Br J Urol 57:525–529
Griffiths D, Harrison G, Moore K et al (1994) Long-term changes in urodynamics studies of voiding in the elderly. Urol Res 22:235–238
Griffiths D, Höfner K, van Mastrigt R et al (1997) Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn 16:1–18
Griffiths K, Coffey D, Cockett AT et al (1996) The regulation of prostatic growth. In: Cockett ATK, Khoury S, Aso Y et al (eds) The 3rd international consultation on benign prostatic hyerplasia (BPH). Scientific Communication International Ltd, Monaco, pp 73–121
Hampson SJ, Noble JG, Richards D et al (1992) Does residual urine predispose to urinary tract infection? Br J Urol 70:506–508
Harzmann R, Weckermann D (1995) Diagnostik und Therapie des Prostataadenoms – Bewährtes und Neues. Med Welt 46:454–457
Hill B, Belville W, Bruskewitz RC et al (2004) Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 171:2336–2340
Hoffman RM, MacDonald R, Monga M et al (2004) Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int 94:1031–1036
Höfner K, Kramer AEJL, Tan HK et al (1995) CHESS classification of bladder-outflow obstruction. A consequence in the discussion of current concepts. World J Urol 13:59–64
Homma Y, Gothoh M, Takei M et al (1998) Predictability of conventional tests for the assessment of bladder outflow obstruction in benign prostatic hyperplasia. Int J Urol 5:61–66
Jacobsen SJ (1995) Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology 45:64–69
Jacobsen SJ, Jacobson DJ, Girman CJ et al (1997) Natural history of prostatism: risk factors for acute urinary retention. J Urol 158:481–487
Jacobsen SJ, Jacobsen DJ, Girman CJ et al (2003) Acute urinary retention in community-dwelling men: 9-year follow-up of the Olmsted County study of urinary symptoms and health status among men. J Urol 169: 1364
Javle P, Jenkins SA, West C et al (1996) Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy. J Urol 156:1014–1019
Jensen KM, Bruskewitz RC, Iversen P et al (1983) Predictive value of voiding pressures in benign prostatic hyperplasia. Neurourol Urodyn 2:117–125
Jonas U, Höfner K (1996) Symptom scores, watchful waiting and prostate specific antigen levels in benign prostatic hyperplasia. J Urol 156:1040–1041
Kaplan SA, Reis RB (1996) Significant correlation of the American Urological Association symptom score and a novel urodynamic parameter: Detrusor contraction duration. J Urol 156:1668–1672
Kaplan SA (2006) Update on the American Urological Association guidelines for the treatment of benign prostatic hyperplasia. Rev Urol 8(Suppl 4):10–17
Kessler TM, Gerber R, Burkhard FC et al (2006) Ultrasound assessment of detrusor thickness in men - can it predict bladder outlet obstruction and replace pressure flow study? J Urol 175:2170–2173
Koch WR, El Din KE, de Wildt MJ et al (1996) The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 155:186–189
Kojima M, Inui E, Ochiai A et al (1996) Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report. Urology 47:942–947
Kojima M, Inui E, Ochiai A et al (1997) Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol 157:476–479
Kurita Y, Masuda H, Terada H et al (1998) Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 51:595–600
Kursh ED, Concepcion R, Chan S et al (2003) Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Urology 61(3):573–578
Levin RM, Haugaard N, O‚Connor L et al (2000) Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison. Neurourol Urodyn 19:609–629
Lieber MM, Jacobsen DJ, Girman CJ et al (2003) Incidence of lower urinary tract symptom progression in community-dwelling men: 9-year follow-up of the Olmsted County study of urinary symptoms and health status among men. J Urol 169:1369
Madersbacher S, Klingler HC, Diavan B et al (1997) Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? Br J Urol 80:72–77
Madersbacher S, Alivizatos G, Nordling J et al (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554
Madsen FA, Bruskewitz RC (1995) Cystoscopy in the evaluation of benign prostatic hyperplasia. World J Urol 13:14–16
Manieri C, Carter SS, Romano G et al (1998) The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol 159:761–765
Marberger MJ, Andersen JT, Nickel JC et al (2000) Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol 38:563–568
Mattiasson A, Wagrell L, Schelin S et al (2007) Five-year follow-up of Feedback Microwave Thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 69:91–97
McConnell J, Bruskewitz R, Walsh P et al (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 338:557–563
McConnell JD, Roehrborn CG, Slawin KM et al (2003) Baseline measures predict the risk of benign prostatic hyperplasia clinical progression in placebo-treated patients. J Urol 169:1287
Meigs JB, Barry MJ, Giovannucci E et al (1999) Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol 162:376–382
Minardi D, Garofalo F, Yehia M et al (2001) Pressure-flow studies in men with benign prostatic hypertrophy before and after treatment with transurethral needle ablation. Urol Int 66:89–93
Mochtar CA, Kiemeney LA, van Riemsdijk MM et al (2006) Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol 175:213–216
Nathan MS, Seenivasagam K, Mei Q et al (1996) Transrectal ultrasonography: why are estimates of prostate volume and dimension so inaccurate? Br J Urol 77:401–407
Netto NR, D’Ancona CAL, Lopes de Lima M (1996) Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia. J Urol 155:200–202
Oelke M, Höfner K, Wiese B et al (2002) Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol 19:443–452
Oelke M, Höfner K, Jonas U et al (2006) Ultrasound measurement of detrusor wall thickness in healthy adults. Neurourol Urodyn 25:308–317
Oelke M, Höfner K, Jonas U et al (2007) Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol 52:827–834
Reynard JM, Yang Q, Donovan JL et al (1998) The ICS-’BPH‘ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 82:619–623
Rigatti L, Naspro R, Salonia A et al (2006) Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up? Urology 67:1193–1198
Roehrborn CG, Chinn HK, Fulgham PF et al (1986) The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. J Urol 135:1190–1193
Roehrborn CG, Girman CJ, Rhodes T et al (1997) Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 49:548–557
Roehrborn CG, Boyle P, Bergner D et al (1999) Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology 54:662–669
Roehrborn CG, Boyle P, Gould AL et al (1999) Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53:581–589
Roehrborn CG, McConnell JD, Lieber MM et al (1999) Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 53:473–480
Roehrborn CG, McConnell J, Bonilla J et al (2000) Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 163:13–20
Roehrborn CG, McConnell JD, Saltzman B et al (2002) Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol 42:1–6
Rosier PF, de la Rosette JJ (1995) Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol 13:9–13
Rosier PF, de la Rosette JJ, Koldewijn EL et al (1995) Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia. J Urol 153:1520–1525
Rossi C, Kortmann BB, Sonke GS et al (2001) alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. J Urol 165:38–41
Rule AD, Jacobson DJ, McGree ME et al (2005) Longitudinal changes in post-void residual and voided volume among community dwelling men. J Urol 174:1317–1321
Rule AD, Lieber MM, Jacobsen SJ (2005) Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol 173:691–696
Schäfer W (1985) Urethral resistance? Urodynamic concepts of physiological and pathological bladder outlet function during voiding. Neurourol Urodyn 4:161–201
Schäfer W, Tammela TL, Barrett DM et al (1999) Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years Finasteride Urodynamics Study Group Urology 54:278–283
Schleicher C, Neumann R, Kaiser WA et al (1997) Zur Indikation der intravenösen Urographie. Med Klin 92:79–82
Steele GS, Sleep DJ (1997) Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup. J Urol 158:1834–1838
van Venrooij GEPM, Boon TA (1996) The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis. J Urol 155:2014–2018
Witjes WP, de Wildt MJ, Rosier PF et al (1996) Variability of clinical and pressure-flow study variables after 6 month of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement. J Urol 156:1026–1034